scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043957183 |
P356 | DOI | 10.1007/S00430-012-0248-Z |
P698 | PubMed publication ID | 22684724 |
P5875 | ResearchGate publication ID | 225287293 |
P2093 | author name string | Basel K Al-Ramadi | |
Maria J Fernandez-Cabezudo | |||
C B Tara Moore | |||
Samia M Al-Ojali | |||
P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | Q24290619 | ||
High Susceptibility of Strain A Mice to Endotoxin and Endotoxin-Red Blood Cell Mixtures | Q24616353 | ||
A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors | Q33557714 | ||
Role of gamma interferon in late stages of murine salmonellosis | Q33610996 | ||
Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. | Q33753467 | ||
Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport | Q33840586 | ||
Immune response to infection with Salmonella typhimurium in mice | Q33894349 | ||
Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo | Q33915925 | ||
Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium | Q34002047 | ||
Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha | Q34008045 | ||
Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses | Q34009711 | ||
The role of gamma interferon in antimicrobial immunity | Q34265039 | ||
Cytokines in host defense against Salmonella | Q34469758 | ||
Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity | Q34515348 | ||
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans | Q34562262 | ||
Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors | Q35047221 | ||
Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. | Q35533712 | ||
Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha | Q35560441 | ||
Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent | Q35617117 | ||
Bacterial infection as assessed by in vivo gene expression | Q35966527 | ||
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) | Q36367812 | ||
Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. | Q36380558 | ||
Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage. | Q36441108 | ||
Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis | Q36951389 | ||
Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection | Q36957625 | ||
Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium | Q39509475 | ||
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. | Q39827277 | ||
Modulation of macrophage proinflammatory functions by cytokine-expressing Salmonella vectors | Q39932649 | ||
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity | Q40426239 | ||
Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice | Q40825674 | ||
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans | Q41886615 | ||
Activation of innate immune responses by IL-2-expressing Salmonella typhimurium is independent of Toll-like receptor 4. | Q47352587 | ||
Delivery of epitopes by the Salmonella type III secretion system for vaccine development | Q47793303 | ||
Poor survival but high immunogenicity of IL-2-expressing Salmonella typhimurium in inherently resistant mice | Q47860145 | ||
Toll-like receptors are temporally involved in host defense | Q47914772 | ||
Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance | Q50052089 | ||
Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis | Q50058791 | ||
CD154 is essential for protective immunity in experimental salmonella infection: evidence for a dual role in innate and adaptive immune responses | Q50084899 | ||
Induction of innate immunity by IL-2-expressing Salmonella confers protection against lethal infection | Q50104952 | ||
Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection | Q50122081 | ||
Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. | Q50131250 | ||
Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location | Q50139291 | ||
Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo | Q50180383 | ||
The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response | Q50201535 | ||
Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection | Q50207681 | ||
Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice | Q50214359 | ||
Genetic Control of Leucocyte Responses to Endotoxin | Q50245835 | ||
P433 | issue | 1 | |
P921 | main subject | toll-like receptor | Q408004 |
attenuated vaccine | Q1810913 | ||
Salmonella enterica | Q2264864 | ||
P304 | page(s) | 49-61 | |
P577 | publication date | 2012-06-10 | |
P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
P1476 | title | IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice | |
P478 | volume | 202 |
Q55512573 | Induction of Hypergammaglobulinemia and Autoantibodies by Salmonella Infection in MyD88-Deficient Mice. | cites work | P2860 |
Search more.